Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 003

PHASE3CompletedINTERVENTIONAL
Enrollment

900

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

May 31, 2006

Study Completion Date

August 31, 2006

Conditions
Meningitis
Interventions
BIOLOGICAL

ACYW135 Meningococcal Polysaccharide Vaccine

600 subjects were divided into three groups (200 subjects in each group), adult (16\~30 years of age), early youth (7\~15 years of age) and children (2\~6 years of age) to receive Group ACYW135 Meningococcal Polysaccharide Vaccine, 0.5 ml, one dose regime

BIOLOGICAL

A+C Meningococcal Polysaccharide Vaccine

300 subjects were divided into three groups (100 subjects in each group), adult (16\~30 years of age), early youth (7\~15 years of age) and children (2\~6 years of age) to receive Group AC Meningococcal Polysaccharide Vaccine, 0.5 ml, one dose regime

All Listed Sponsors
lead

Hualan Biological Engineering, Inc.

INDUSTRY